Samuel K. Ackerman

Cyclis Pharmaceuticals, Inc. researches and develops small molecule drugs for the treatment of cancer. It is engaged in the discovery and development of novel drugs which are based on the restoration and activation of cellular checkpoints. The company is headquartered in Norwood, MA.

Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development

Part of Sanofi, OraVax, Inc. is a company that has a slick name that taps into the words 'oral' and 'vaccine' in a subtle way. The company is based in Cambridge, MA. The company is a possible oral health brand, medical licensing service, app, or chemicals company. OraVax was acquired by Acambis Plc, part of Sanofi from September 22, 2008 on May 11, 1999 for $17.79 million.

Pentose Pharmaceuticals, Inc. develops and commercializes novel antiviral products for medical use based on innovative applications of nucleic acid chemistry. Pentose is a privately held biopharmaceutical company founded in 1995 and is based in Cambridge, Massachusetts.

Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts.